Research Nester released a report titled “CyberKnife Radiation Therapy For Lung Cancer Treatment Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global CyberKnife radiation therapy for lung cancer treatment market in terms of market segmentation by component, by end user and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Lung cancer is a commonly occurring chronic condition, especially among smokers. The treatment methods for this form of cancer include radiation therapy that aims at providing radiation beams towards the target cancerous area. CyberKnife is a radiation therapy system that is completely robotic in nature and does not require any manual assistance. The CyberKnife radiation therapy for lung cancer treatment market is anticipated to observe a significantly high CAGR during the forecast period, i.e., 2019-2027. The market is segmented by component, by end user and by region. On the basis of end user, the market is segmented into hospitals, radiation therapy centers and ambulatory centers, out of which, the largest share in the market is estimated to be held by the radiation therapy centers. This can be attributed to the rising number of cancer patients and increasing preference of improved and effective treatments at radiotherapy centers by them.

The market in North America is anticipated to continue to retain the largest share in the CyberKnife radiation therapy for lung cancer treatment market on account of better medical facilities available in the region and advancements in technology in the healthcare industry. The market in Asia-Pacific region is estimated to grow at the highest rate during the forecast period as a result of growing demand for CyberKnife radiation therapy centers in the region.

Increasing Prevalence Of Lung Cancer To Propel The Market Growth

As per the National Cancer Institute, there were around 15.5 million cancer survivors in the United States in 2016 which were estimated to increase to 20.3 million people by 2026. The high number of lung cancer cases among people across the globe is increasing the demand for effective radiation therapy techniques. This is anticipated to be responsible for growth of the market during the forecast period.

However, the lack of skilled medical professionals and radiotherapists, especially in low and middle income countries, is estimated to restrict the market growth.

This report also provides the existing competitive scenario of the global CyberKnife radiation therapy for lung cancer treatment market which includes company profiling of Accuray (ARAY). The profiling enfolds key information of the company which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global CyberKnife radiation therapy for lung cancer treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.